Abstract
Schizophrenia is a debilitating mental disorder that affects 0.29% of the world's population. Despite having medications aimed at treating the symptoms of schizophrenia, such drugs induce serious adverse effects and are only effective in treating the positive symptoms of the disorder. For this reason, new therapeutic alternatives have been studied, with our group focusing on cannabinoid c…